2021 NF1 Diagnostic Criteria Update and Comparison of Changes
Home / Blog / 2021 NF1 Diagnostic Criteria Update and Comparison of Changes
An update of the diagnostic criteria for neurofibromatosis type 1 has been published in Genetics in Medicine, the official journal of the American College of Medical Genetics and Genomics. This is an update to the original diagnostic criteria that was established at the National Institutes of Health (NIH) in 1987. The new criteria are the result of years of work and collaboration of over 90 neurofibromatosis (NF) experts from around the world.
The goal of the new criteria is to allow for earlier and more accurate diagnosis of NF1, leading to improved care. Publication of new criteria for NF2-related schwannomatosis and schwannomatosis is also planned.
The table below compares the original criteria with the 2021 update to help our community understand the changes. The Children’s Tumor Foundation (CTF) has also provided a helpful infographic.
ORIGINAL DIAGNOSTIC CRITERIA (1988)
UPDATED DIAGNOSTIC CRITERIA (2021)
A diagnosis of NF1 can be given if an individual has two or more of the following manifestations:
Six or more café-au-lait macules (brown skin spots)
greater than 5mm in pre-pubertal children
greater than 15mm in post-pubertal individuals
Freckling in axilla (armpit) or groin
Two or more neurofibroma tumors of any type, or one plexiform neurofibroma
Two or more iris Lisch nodules (iris hamartomas)
Optic glioma
A distinctive bony lesion: dysplasia (abnormal growth) of the sphenoid bone behind the eye, or dysplasia of long bones, often in the lower leg
Having a close relative (parent, sibling, or child) with NF1
A diagnosis of NF1 can be given if an individual has two or more of the following manifestations:
Six or more café-au-lait-macules* (brown skin spots)
greater than 5mm in pre-pubertal children
greater than 15mm in post-pubertal individuals
Freckling in axilla (armpit) or groin*
Two or more neurofibroma tumors of any type, or one plexiform neurofibroma
Two or more Lisch nodules or two or more choroidal abnormalities
Optic pathway glioma (tumor of the visual pathway)
A distinctive osseous lesion such as: sphenoid dysplasia; anterolateral bowing of tibia (tibial dysplasia); or pseudarthrosis of a long bone
A pathogenic NF1 gene variant **
A parent with NF1 by the above criteria
*At least one of the two pigmentary findings (café-au-lait macules or freckling) should be bilateral.
Offered by: University of Colorado AnschutzConducted by: Katelyn Glowinski, genetic counseling student, master’s program This research study is designed to gain a better understanding of healthcare barriers faced by adults with Neurofibromatosis Type 1 (NF1), as well as evaluate any associations between these barriers and your self-reported neuropsychiatric or mental health status. If you join... Read More
Rachel was 13 when she first attended Camp NF. At an age when so much was changing, camp gave her something she deeply needed: the chance to meet other young people who understood life with NF. “NF camp gave me the opportunity to connect with others who had a shared experience and come to understand... Read More
Responses